Interleukin-6 As a Risk and Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis. J. Can. Res. Updates 2024, 13, 42-51. https://doi.org/10.30683/1929-2279.2024.13.07.